These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14567251)

  • 21. Celecoxib does not induce convulsions nor does it affect GABAA receptor binding activity in the presence of new quinolones in mice.
    Yoshino T; Noguchi M; Okutsu H; Kimoto A; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):69-76. PubMed ID: 15659296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of the quinolone-theophylline interaction using the Food and Drug Administration spontaneous reporting system.
    Grasela TH; Dreis MW
    Arch Intern Med; 1992 Mar; 152(3):617-21. PubMed ID: 1312320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adverse drug interactions between pyridonecarboxylic acids and nonsteroidal antiinflammatory drugs: convulsion after oral or intracerebral administration in mice].
    Hirai S; Tanaka K; Makino S; Narita H
    Yakugaku Zasshi; 1989 Feb; 109(2):119-26. PubMed ID: 2746470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system toxicity of quinolones: human and animal findings.
    Christ W
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring.
    Kubota K; Kubota N; Pearce GL; Prescott P; Mann RD
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):219-25. PubMed ID: 7620692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bactericidal activity of quinolones (including sparfloxacin) against Enterococcus; in vitro antagonisms with gentamicin].
    Watine J; Charet JC
    Pathol Biol (Paris); 1997 May; 45(5):430-2. PubMed ID: 9296098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quinolones and their central nervous system toxicities].
    Hori S; Kageyama S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):552-7. PubMed ID: 10434720
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction between enoxacin, a new antimicrobial, and nimesulide, a new non-steroidal anti-inflammatory agent in mice.
    Taniguchi Y; Deguchi Y; Noda K
    Inflamm Res; 1996 Aug; 45(8):376-9. PubMed ID: 8872509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.
    Kita H; Matsuo H; Takanaga H; Kawakami J; Yamamoto K; Iga T; Naito M; Tsuruo T; Asanuma A; Yanagisawa K; Sawada Y
    Antimicrob Agents Chemother; 1999 May; 43(5):1091-7. PubMed ID: 10223919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective observational study of medication errors in general medicine department in a tertiary care hospital.
    Karthikeyan M; Lalitha D
    Drug Metabol Drug Interact; 2013; 28(1):13-21. PubMed ID: 23314531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-steroidal anti-inflammatory drug and antacid co-prescription in Taiwan: analysis of national insurance claims.
    Chen TJ; Liu JY; Hwang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):588-93. PubMed ID: 12636204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian variation in enoxacin-induced convulsions in mice coadministered with fenbufen.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1997 Feb; 73(2):175-7. PubMed ID: 9074952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolones and fenbufen interact with GABAA receptor in rat isolated CA1 pyramidal neurons.
    Akaike N; Shirasaki T; Yakushiji T
    Acta Physiol Scand Suppl; 1989; 582():21. PubMed ID: 2554677
    [No Abstract]   [Full Text] [Related]  

  • 35. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
    Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of antimicrobial susceptibilities of strains clinically isolated at 8 institutions in Hiroshima City to major oral antimicrobial drugs, mainly new quinolone drugs. Hiroshima Levofloxacin Susceptibility Surveillance Group].
    Fujiue Y; Kuwabara M; Muroki K; Kohara T; Itaha H; Yamasaki M; Sasaki M; Onimura K; Shigemitsu M; Kashiyama S
    Jpn J Antibiot; 2000 Jun; 53(6):409-21. PubMed ID: 10955237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
    Tozawa K; Washida H; Honma H; Kang K; Yamada Y
    Hinyokika Kiyo; 1993 Sep; 39(9):801-5. PubMed ID: 8213373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks associated with the therapeutic use of fluoroquinolones.
    Stahlmann R; Lode HM
    Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of indomethacin co-administration on ofloxacin levels in plasma and cerebrospinal fluid in rats.
    Dontas I; Sokolis DP; Giamarellos-Bourboulis EJ; Tzonou A; Giamarellou H; Karayannacos PE
    Int J Antimicrob Agents; 2004 Apr; 23(4):371-6. PubMed ID: 15081086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.